The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Share News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.878
Bid: 0.878
Ask: 0.882
Change: -0.002 (-0.23%)
Spread: 0.004 (0.456%)
Open: 0.882
High: 0.882
Low: 0.876
Prev. Close: 0.88
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Anglo Asian to restart Gedabek operations on approval

Tue, 26th Sep 2023 21:47

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Anglo Asian Mining PLC - Copper, gold and silver producer focused on Azerbaijan - Says the final Micon report was delivered on Tuesday to the company and the Government of Azerbaijan. Following the receipt of the report, the Prime Minister of Azerbaijan issued a press release saying that based on the report, the Gedabek plant can gradually restart operations. The restart of operations will take place in accordance with a timetable to be agreed with the Government. Anglo Asian and the government will also work together to implement Micon's recommendations for the Gedabek operation contained in the report.

----------

BSF Enterprise PLC - London-based biotechnology investor - Confirms allotment of 364,739 ordinary shares, constituting the 264,739 second tranche shares and the 100,000 financial PR shares, conditional to trading on the London Stock Exchange's Main Market at an issue price of 17 pence per share. Expects that admission will become effective on Wednesday.

----------

Power Metal Resources PLC - Metals exploration company focused on North America, Africa, and Australia - Hails escalation of high priority uranium target, based on a remote sensing study at its Badger Lake uranium project located in the Athabasca Basin, Saskatchewan, Canada. Says analysis finds distinct similarities between Badger Lake and the Arrow Deposit, owned and operated by Nexgen Energy Ltd. Plans to expedite the planned high-resolution electromagnetic UAV survey over Badger Lake, and reemphasises that the target at Badger Lake is an "extremely attractive exploration target". Chief Executive Officer Sean Wade says: "These findings could not come at a better time for shareholders and serve to highlight the huge potential value inherent in our uranium portfolio and in the Power Metal business model more generally."

----------

Ediston Property Investment Co PLC - London-based real estate investment trust focused on UK commercial property - Says shareholders have approved the sale of EPIC Group's property portfolio to RI UK 1 Ltd, a wholly owned subsidiary of Realty Income, for GBP200.8 million. This is prior to agreed deductions of approximately GBP4.0 million.

----------

Amte Power PLC - London-based lithium-ion and sodium-ion battery cells developer and manufacturer - Says shares were restored to trading on Tuesday in London at 1330 BST. Follows announcement on Monday that Amte would make an announcement regarding the launch of a retail offer following the lifting of the suspension of trading.

----------

Grafenia PLC - Manchester-based printing and software company - Says it will formally change its name to Software Circle PLC "in the coming days", as the relevant paperwork has been filed with Companies House. Adds that a further announcement will be made when the name change is formally effective. Upon the change of name becoming effective, the company's TIDM will change from "GRA" to "SFT". The ISIN and SEDOL numbers will remain unchanged.

----------

Croda International PLC - Yorkshire, England-based chemicals firm - Says Nicholas Ian Challoner, a member of the executive committee, sells 6,339 shares in the company at GBP49.16 each, coming to a total of GBP311,617 in shares.

----------

BioPharma Credit PLC - Specialist life sciences debt investment trust - Notes filing by LumiraDx Ltd, which discloses an amendment to the loan agreement entered into with BioPharma Credit PLC, BPCR Ltd Partnership, and BioPharma Credit Investments V LP. On September 25, LumiraDx entered into a twelfth amendment and waiver to the loan agreement of March 31. This amendment made several stipulations, including that the minimum liquidity covenant in the agreement is waived until October 11, provided that the consolidated liquidity of the company and its subsidiaries during this waiver period must be at least USD5 million, that the minimum net sales covenant for the trailing twelve-month period ended June 30 is waived. BioPharma Credit expects that the USD3.0 million Tranche D loan amount will be funded on Wednesday.

----------

ActiveOps PLC - Reading, England-based management process automation software provider for back-office operations - Launches ControliQ Series 3, a new version of its management process automation product. Says that ControliQ Series 3 has additional artifical intelligence features. Following the official launch in August, customers across multiple geographies and sectors are already using the new capabilities. ActiveOps intends to launch the ControliQ Series 4 in 2024.

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 Oct 2020 16:55

UK DIRECTOR DEALINGS SUMMARY: Amigo CEO Buys 500,000 Shares

UK DIRECTOR DEALINGS SUMMARY: Amigo CEO Buys 500,000 Shares

Read more
28 Sep 2020 17:28

IN BRIEF: BioPharma Credit Amends Loan With Sarepta Therapeutics

IN BRIEF: BioPharma Credit Amends Loan With Sarepta Therapeutics

Read more
16 Sep 2020 17:51

IN BRIEF: BioPharma Credit Net Asset Value Dips; Portfolio "Resilient"

IN BRIEF: BioPharma Credit Net Asset Value Dips; Portfolio "Resilient"

Read more
16 Sep 2020 16:08

UK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec

UK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec

Read more
9 Sep 2020 19:21

IN BRIEF: BioPharma Credit Secures USD124.5 Million Lexicon Repayment

IN BRIEF: BioPharma Credit Secures USD124.5 Million Lexicon Repayment

Read more
9 Sep 2020 16:00

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
7 Aug 2020 11:02

IN BRIEF: Biopharma Credit's Portfolio Value To Increase On New Loans

IN BRIEF: Biopharma Credit's Portfolio Value To Increase On New Loans

Read more
21 Jul 2020 19:02

IN BRIEF: BioPharma Credit To Ink USD156.2 Million From Amicus

IN BRIEF: BioPharma Credit To Ink USD156.2 Million From Amicus

Read more
18 Jun 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
26 May 2020 18:05

BioPharma Credit Agrees USD200 Million Credit Facility With JPMorgan

BioPharma Credit Agrees USD200 Million Credit Facility With JPMorgan

Read more
10 Mar 2020 11:46

BioPharma Credit Meets Dividend Target In 2019 As Net Assets Rise

BioPharma Credit Meets Dividend Target In 2019 As Net Assets Rise

Read more
20 Feb 2020 18:17

BioPharma Credit Declares Interim Dividend Of USD0.0303 Per Share

BioPharma Credit Declares Interim Dividend Of USD0.0303 Per Share

Read more
7 Feb 2020 11:01

BioPharma Credit To Provide USD200 Million Loan To Collegium Pharma

BioPharma Credit To Provide USD200 Million Loan To Collegium Pharma

Read more
7 Feb 2020 09:53

BioPharma Credit puts $165m into pharma firm Collegium via loan

(Sharecast News) - Specialist life sciences investor BioPharma Credit has entered into a definitive senior secured term loan agreement with Collegium Pharmaceutical, alongside the BioPharma-V fund, it announced on Friday.

Read more
18 Dec 2019 17:54

BioPharma Credit Invests USD82.5 Million In Global Blood Therapeutics

BioPharma Credit Invests USD82.5 Million In Global Blood Therapeutics

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.